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coverage of at least 95% of the prescribed dose was achieved, the 
treatment plan would be considered as clinical acceptable.  
Results: D99% coverage for the gold standard CTV was achieved in for 
69% of the patients using a margin of 1/4 mm in/out of plane, for the 
propagated CTV, which is about the voxel size of the MRI. D99% 
coverage for the gold standard GTV of was achieved for 89% of the 
patients using a margin of 8/8 mm in/out of plane for the propagated 
GTV. OAR doses remained far less then clinical criteria in all 
treatment plans. All treatment plans were made using a class solution 
objectives set. 
 
 
Conclusions: Online MRI-guided ART seems feasible using only a small 
margin added to the automatically generated contours. Failures were 
seen only in patients with large daily variations in rectum filling. 
Currently, the used DIR method cannot account for these large 
deformations. Further improvements on the DIR have to be made to 
make feasible treatment plans for these patients in an automated 
workflow. For delivering the GTV boost, a somewhat larger margin 
was needed and needs to be further optimized.  
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Purpose/Objective: Hyperthermia is a clinical application of heat in 
which tumour temperatures are raised to 40-45°C. Hyperthermia is a 
proven radiosensitizer, which significantly improves clinical outcome 
for several tumour sites. Contrary to most anti-cancer treatments 
hyperthermia has no serious side effects when administered properly. 
Therefore, hyperthermia might be a good alternative for dose 
escalation, for instance for treatment of prostate tumours. This is 
expected to improve tumour control, while avoiding an increase in 
dose to organs at risk; e.g. the rectum. 
Purpose: of this study was to develop a method to quantify the 
therapeutic effect of radiosensitization by hyperthermia. To this end, 
a numerical method was proposed to convert radiotherapy dose 
distributions with hyperthermia to equivalent dose distributions 
without hyperthermia. 
Materials and Methods: For 15 prostate cancer patients clinical IMRT 
plans were created. Patients received a total dose of 70 Gy on the 
PTV, delivered in 35 fractions of 2 Gy, with an integrated boost 
delivering 77 Gy to the prostate. To simulate a clinically relevant 
heterogeneous temperature distribution, hyperthermia treatment 
planning was performed for heating with the 70 MHz AMC-8 system 
using our in-house developed treatment planning system. The 
temperature dependent parameters α (Gy-1) and β (Gy-2) of the linear-
quadratic model (LQ-model) for prostate cancer were estimated from 
literature. In line with clinical observations, no thermal effect was 
assumed for normal tissue. The IMRT plans and temperature 
distributions were exported to our in-house developed research 
radiotherapy treatment planning system and equivalent dose 
distributions without hyperthermia were calculated using the LQ-
model. 
Results: The average tumour temperatures T90, T50 and T10 in the 
PTV were 40.5°C, 41.6°C and 42.4°C, respectively. The minimum, 
maximum and average radiotherapy doses were 62.9 Gy, 81.0 Gy and 
76.0 Gy, respectively. The equivalent minimum, maximum and 
average dose reflecting the radiosensitization by hyperthermia were 
70.3 Gy, 93.6 Gy and 86.3 Gy, respectively, for a linear increase of α 
with temperature. This can be considered similar to a dose escalation. 
Furthermore, the PTV coverage by the 95% isodose level improved by 
adding hyperthermia (Fig. 1). In IMRT dose optimization the dose to 
organs at risk (e.g. the rectum) can be a limiting factor, yielding 
under-dosage in a part of the PTV. Hyperthermia reduces the impact 
of these limitations. 
 
 
Conclusions: A model to quantify the effect of combined 
hyperthermia and radiotherapy in terms of equivalent dose 
distributions was presented. Adding hyperthermia can be considered 
similar to a dose escalation. This model is useful to predict interaction 
of different cancer treatments and may be very helpful in discussions 
on dose escalation.  
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Purpose/Objective: Historically a number of techniques have been 
described that use combined photon and electron fields to conform 
the dose with depth. In recent years however this sort of treatment 
has largely been replaced with photon IMRT. It is proposed that to 
further improve dose distributions electron fields could be re-
introduced to IMRT. The electron beam limited range and large 
penumbra could be balanced by modulating with photon MLC and 
combining with existing photon IMRT techniques. By finding the 
optimum mix of electron energies and photons it may be possible to 
reduce exposure to critical organs and reduce integral doses. The 
perceived disadvantages of high surface dose characterising electron 
beams becomes an advantage for cases where the CTV extends to the 
surface. 
The purpose of this study is to develop a novel optimisation algorithm 
for combined electron and photon IMRT that allows spatial and energy 
modulation with standard unmodified linacs. 
Materials and Methods: Isocentric electron beamlets delivered 
through the photon MLC of an Elekta linac were calculated using 
BEAMnrc Monte Carlo dose simulations. The CERR environment (A 
Computational Environment for Radiotherapy Research, Washington 
University Medical Centre) was used to manipulate the electron 
beamlets and to calculate photon beamlets using the quadrant infinite 
beam (QIB) dose calculation engine within CERR. An algorithm was 
then developed to optimise the combined electron and photon dose 
distribution. Beams are manually positioned to cover the target, with 
a single electron field positioned as a boost over the superficial 
section of tumour. The optimisation is then split into three stages. (1) 
